PHOENIX, Feb. 2, 2022 /PRNewswire/ -- Item 9 Labs Corp. INLB (the "Company")—a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products—announced today that it will host a conference call on Tuesday, February 15, 2022 to discuss financial results for the first quarter of fiscal year 2022, ended December 31, 2021. The 10K will be filed on Monday, February 14, 2022.
Item 9 Labs Corp. CEO Andrew Bowden and CFO Bobby Mikkelsen will host the conference call.
Q1 FY2022 Earnings Call Details
- Date: Tuesday, February 15, 2022
- Time: 2 p.m. Eastern time (11 a.m. Pacific time)
- Access by Zoom: A live and archived webcast will be available via Sequire, click on this webcast link to register or access the replay.
- Access by Phone: Please call the conference telephone number 10-15 minutes prior to the start time: Dial-in number: 669-900-6833 // Meeting ID: 96850773091 // Passcode: 926987
- Questions: Please submit questions to investors@item9labs.com before the presentation begins. The management team will do their best to answer all questions.
About Item 9 Labs Corp.
Item 9 Labs Corp. INLB is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 640,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit https://investors.item9labscorp.com/.
Media Contact:
Item 9 Labs Corp.
Jayne Levy, VP of Communications
Jayne@item9labs.com
Investor Contact:
Item 9 Labs Corp.
800-403-1140
investors@item9labs.com
SOURCE Item 9 Labs Corp.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
